March 10, 2025
With a designation from the FDA, a device created and patented by Flavio Frohlich, PhD, professor of psychiatry at the UNC School of Medicine and member of the UNC Neuroscience Center, is one step closer to being available for patients.
January 23, 2025
Building off previous groundbreaking research, a new study identifies specific genetic variants that have significant impacts on brain development and are shared across eight different psychiatric disorders. Targeting these variants could pave the way for treatments that address multiple conditions at once.
December 20, 2024
Physicians need more training to improve care for autism patients, UNC School of Medicine OBGYN Dr. Lauren Schiff writes in the New England Journal of Medicine.
December 16, 2024
Athena Stein, postdoctoral researcher in the lab of Flavio Frohlich, PhD, professor of psychiatry, is developing next-generation non-invasive brain stimulation treatments alongside her new family in the lab.
October 15, 2024
U.S. Department of Defense awarded $2.8 million to UNC Institute for Trauma Recovery researchers led by Samuel McLean, MD, to test the safety and efficacy of BXCL501 – sublingual dexmedetomidine created by BioXcel Therapautics for treating acute stress reaction symptoms and preventing posttraumatic stress.
October 2, 2024
UNC Center for Excellence in Community Mental Health unveils the Farm at Penny Lane Food Shuttle, made possible with $100,000 in funding from UnitedHealthcare.
September 17, 2024
The National Institutes of Mental Health awarded a $2.5-million grant to UNC School of Medicine researchers Adam Bryant Miller, PhD, and Andrea Pelletier-Baldelli, PhD, in the UNC Department of Psychiatry, to study the alarming rise of suicidal behavior in young girls.
August 26, 2024
In a small pilot study, UNC School of Medicine researchers led by Flavio Frohlich, PhD, used a new closed-loop system to measure the electrical brain patterns of individual patients and then stimulate those patterns with a weak electrical current, resulting in significantly improved symptoms of major depressive disorder.
August 2, 2024
A new review article written by Patrick Sullivan, MD, FRANZCP, the Yeargan Distinguished Professor of Psychiatry and Genetics, outlines the genetic foundations for schizophrenia.
June 25, 2024
Christian Hendershot, PhD, associate professor of psychiatry and director of the Clinical and Translational Addiction Research Program at the UNC School of Medicine, presented early findings from the first completed randomized controlled trial of semaglutide for reducing alcohol consumption in heavy drinkers.
June 19, 2024
Headspace, the popular wellness app, is available to UNC Health Employees, a partnership highlighted in a two-part episode of the TarHeal Wellness podcast exploring the partnership and available resources, including evidence-based meditation and mindfulness tools, mental health coaching, therapy, psychiatry, and family support.
May 13, 2024
The UNC School of Medicine lab of Zoe McElligott, PhD, and colleagues found that the animal tranquilizer xylazine activates opioid receptors in the brain, suggesting a reason why the treatment naloxone triggers a more severe withdrawal response when given to individuals on fentanyl/xylazine and suffering from respiratory depression.